Published in Arch Dis Child on February 01, 1980
Saliva carbamazepine and phenytoin level monitoring. Arch Dis Child (1981) 0.82
The role of therapeutic drug monitoring in children. Clin Pharmacokinet (1989) 0.79
Measurement of saliva tacrolimus levels in pediatric renal transplant recipients. Pediatr Nephrol (2010) 0.76
Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol (1960) 4.19
Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med (1975) 3.48
Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J (1974) 3.42
"Continuous" vs. "discontinuous" therapy with penicillin; the effect of the interval between injections on therapeutic efficacy. N Engl J Med (1953) 3.41
Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children. J Pediatr (1974) 3.09
Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther (1977) 3.05
Successful prophylaxis of febrile convulsions with phenobarbital. Epilepsia (1972) 2.94
Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90
Dosage of gentamicin for pseudomonas infections. Br Med J (1967) 2.84
Therapeutic drug monitoring in saliva. Clin Pharmacokinet (1978) 2.66
Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy. Eur Neurol (1975) 2.65
Anticonvulsant effect of diphenylhydantoin relative to plasma levels. A prospective three-year study in ambulant patients with generalized epileptic seizures. Arch Neurol (1974) 2.64
Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents Chemother (1975) 2.48
The serum digitalis concentration--does it diagnose digitalis toxicity? N Engl J Med (1976) 2.47
Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol (1966) 2.33
Pharmacokinetics of theophylline in children with asthma. Pediatrics (1976) 2.31
The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther (1970) 2.23
Plasma-diazepam in infants after rectal administration in solution and by suppository. Acta Paediatr Scand (1977) 2.16
Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia (1975) 2.10
Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis (1971) 1.97
A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy. Epilepsia (1976) 1.96
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. Br J Pharmacol (1971) 1.92
Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin. J Infect Dis (1971) 1.89
Prevention of apnea and bradycardia in low-birthweight infants. Pediatrics (1975) 1.88
Serum theophylline levels in asthmatic children after oral administration of two slow-release theophylline preparations. Arch Dis Child (1978) 1.79
Tissue persistence of gentamicin in man. JAMA (1977) 1.79
Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med (1971) 1.76
Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin Pharmacol Ther (1974) 1.69
Failure of phenobarbitone to prevent febrile convulsions. Br Med J (1976) 1.66
Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur J Clin Pharmacol (1975) 1.60
DIPHENYLHYDANTOIN AND PHENOBARBITAL. SERUM LEVELS IN CHILDREN. Am J Dis Child (1964) 1.56
Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr (1977) 1.52
Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol (1973) 1.49
Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim"). Dev Med Child Neurol (1977) 1.44
Pharmacokinetics of gentamicin in children and adults. J Infect Dis (1975) 1.39
Relationship between digoxin concentrations in serum and saliva. Clin Pharmacol Ther (1975) 1.38
Drug concentration in saliva. Clin Pharmacol Ther (1978) 1.38
Salivary levels of anticonvulsants: a practical approach to drug monitoring. Neurology (1977) 1.37
Use of saliva in therapeutic drug monitoring. Clin Chem (1977) 1.37
Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur J Clin Pharmacol (1975) 1.35
Clinical applications of serum theophylline measurement by high pressure liquid chromatography. Arch Dis Child (1978) 1.33
A method for obtaining saliva samples from infants and young children. Br J Clin Pharmacol (1978) 1.32
Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease. Clin Pharmacol Ther (1974) 1.31
Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia (1975) 1.28
The necessity for monitoring chloramphenicol levels when treating neonatal meningitis. J Pediatr (1978) 1.28
A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm (1973) 1.27
Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther (1975) 1.27
Plasma protein binding of diphenylhydantoin in patients with epilepsy. Agreement between the unbound fraction in plasma and the concentration in the cerebrospinal fluid. Clin Pharmacol Ther (1972) 1.26
Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr (1975) 1.25
Pharmacokinetics of diazepam in dogs, mice and humans. Acta Pharmacol Toxicol (Copenh) (1971) 1.24
Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. Bull Johns Hopkins Hosp (1954) 1.23
Relationship of theophylline clearance to oral dosage in children with chronic asthma. J Pediatr (1977) 1.21
Pharmacology of the metabolites of chlordiazepoxide and diazepam. Curr Ther Res Clin Exp (1965) 1.20
Studies on the concentrations of chloramphenicol in the serum and cerebrospinal fluid of neonates, infants, and small children. Reciprocal reactions between chloramphenicol, penicillin and phenobarbitone. Eur J Pediatr (1977) 1.20
[The significance of cumulation and elimination for the determination of Phenytoin (diphenylhydantoin)]. Dtsch Med Wochenschr (1969) 1.17
Kinetics of carbamazepine and its 10,11-epoxide metabolite in children. Clin Pharmacol Ther (1976) 1.15
Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr (1976) 1.15
Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev (1975) 1.15
Time-course of interaction between carbamazepine and clonazepam in normal man. Clin Pharmacol Ther (1978) 1.12
Phenytoin concentrations in mixed, parotid and submandibular saliva and serum measured by radioimmunoassay. Br J Clin Pharmacol (1977) 1.11
Carbamazepine dose-frequency requirement in children. Arch Dis Child (1979) 1.11
Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin). Acta Neurol Scand Suppl (1975) 1.11
Pharmacokinetic interpretation of data gathered during therapeutic drug monitoring. Clin Chem (1976) 1.07
Patterns of drug prescribing for children in hospital. Eur J Clin Pharmacol (1978) 1.07
Saliva carbamazepine levels in children. Br Med J (1977) 1.06
Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch Dis Child (1979) 1.05
Age-dependent dose response to gentamicin. J Pediatr (1975) 1.05
When should plasma drug levels be monitored? Drugs (1979) 1.03
Clinical pharmacological aspects of valproate sodium. Epilepsia (1977) 1.03
Plasma digoxin levels in infants. Arch Dis Child (1973) 1.02
Diphenylhydantoin concentrations in saliva. Arch Neurol (1974) 1.02
Assays of digitalis in the blood. Prog Cardiovasc Dis (1972) 1.01
The treatment of childhood epilepsy with sodium valproate. Dev Med Child Neurol (1975) 1.01
The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin. Pharmacology (1972) 1.00
Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers. Ann Intern Med (1972) 0.98
Chloramphenicol and phenobarbitone--a drug interaction. Arch Dis Child (1979) 0.98
Plasma level monitoring of anticonvulsants. Clin Pharmacokinet (1976) 0.98
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology (1976) 0.95
Digitalis toxicity: epidemiology and clinical use of serum concentration measurements. Am J Med (1975) 0.95
Serum digoxin studies in infants and children. Pediatrics (1973) 0.95
Effects of digoxin on systolic time intervals of neonates and infants. Circulation (1972) 0.94
One daily dose of diphenylhydantoin for patients with epilepsy. Epilepsia (1974) 0.94
Relation of eeg and seizures to phenobarbital in serum. Arch Neurol (1968) 0.93
Disappearance of phenobarbital and diphenylhydantoin from serum of children. Clin Pharmacol Ther (1970) 0.92
Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia (1979) 0.92
Influence of serum digoxin concentration measurements on frequency of digitoxicity. Clin Pharmacol Ther (1974) 0.90
Metabolic conversion of primidone (mysoline) to phenobarbital. Proc Soc Exp Biol Med (1956) 0.90
Phenytoin kinetics in children. Neurology (1976) 0.89
Indirect plasma-theophylline monitoring in asthmatic children by determination of theophylline concentration in saliva. Pediatrics (1974) 0.88
Salivary concentrations of antiepileptic drugs. Lancet (1976) 0.87
Determination of plasma and cerebrospinal fluid levels of dilantin in the human. Trans Am Neurol Assoc (1960) 0.87
Bacterial meningitis: which regimen? Drugs (1979) 0.86
Interaction of ephedrine and theophylline. Clin Pharmacol Ther (1975) 0.86
Concentration of dipropylacetate in plasma. Epilepsia (1975) 0.85
Abnormal pharmacokinetics of phenytoin in a patient with uraemia. Lancet (1970) 0.85
Carbamazepine: biotransformation. Adv Neurol (1975) 0.84
The relationship of the anticonvulsant properties of primidone to phenobarbital. Epilepsia (1970) 0.83
Gentamicin dosage in children. Arch Dis Child (1976) 0.83
Diphenylhydantoin elimination kinetics in overdosed children. Clin Pharmacol Ther (1975) 0.83
Single daily dose of diphenylhydantoin in children. J Pediatr (1973) 0.83
Age as a determinant of sensitivity to warfarin. Br J Clin Pharmacol (1977) 1.90
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol (1989) 1.88
Consenting patients. BMJ (1990) 1.76
Ciprofloxacin and antacids. Lancet (1986) 1.16
Single dose pharmacokinetics of trimethoprim. Arch Dis Child (1985) 1.15
Does a single plasma phenylalanine predict quality of control in phenylketonuria? Arch Dis Child (1998) 1.14
Carbamazepine dose-frequency requirement in children. Arch Dis Child (1979) 1.11
A comparison of verapamil and digoxin in the treatment of atrial fibrillation. Eur Heart J (1987) 1.10
Patterns of drug prescribing for children in hospital. Eur J Clin Pharmacol (1978) 1.07
Saliva carbamazepine levels in children. Br Med J (1977) 1.06
Adverse reactions to drugs in children. Br Med J (Clin Res Ed) (1987) 1.04
Plasma concentrations of clonazepam after single rectal administration. Arch Dis Child (1986) 1.01
Ethanol kinetics: extent of error in back extrapolation procedures. Br J Clin Pharmacol (1992) 0.96
Medical teaching of the cultural aspects of ethnic minorities: does it exist? Med Educ (1986) 0.95
Re-evaluation of saliva for monitoring theophylline concentrations. Arch Dis Child (1985) 0.95
Rationale for monitoring free drug levels. Clin Pharmacokinet (1984) 0.94
Microsomal enzyme induction in children: the influence of carbamazepine treatment on antipyrine kinetics, 6 beta-hydroxycortisol excretion and plasma gamma-glutamyltranspeptidase activity. Br J Clin Pharmacol (1982) 0.92
Saliva carbamazepine levels in children before and during multiple dosing. Br J Clin Pharmacol (1982) 0.88
The effect of fever on antipyrine metabolism in children. Br J Clin Pharmacol (1982) 0.87
Feeding problems in young PKU children. Acta Paediatr Suppl (1994) 0.87
A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation. Eur Heart J (1988) 0.87
Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother (1987) 0.86
Monitoring saliva anticonvulsant levels in children. Dev Med Child Neurol (1979) 0.84
Parental permission, information, and consent. Arch Dis Child (1991) 0.83
Carbamazepine/valproic acid interaction in man and rhesus monkey. Epilepsia (1984) 0.83
Effects of pethidine and its antagonists on the newborn. Arch Dis Child (1979) 0.83
Saliva carbamazepine and phenytoin level monitoring. Arch Dis Child (1981) 0.82
Serum thiocyanate levels as indicator of passive smoking in children. Lancet (1984) 0.81
Sustained-release verapamil: multiple-dose pharmacokinetic comparison of 120-mg and 240-mg tablets and the effect of halving a 240-mg tablet. J Cardiovasc Pharmacol (1989) 0.80
Liver volume estimation using ultrasound scanning. Arch Dis Child (1982) 0.80
Theophylline dose prediction. Arch Dis Child (1984) 0.78
Studies on a ketone reductase in human and rat liver and kidney soluble fraction using warfarin as a substrate. Biochem Pharmacol (1975) 0.78
Stiripentol kinetics in epilepsy: nonlinearity and interactions. Clin Pharmacol Ther (1984) 0.77
Michaelis-Menten kinetics of stiripentol in normal humans. Epilepsia (1984) 0.77
Naloxone pharmacokinetics in the newborn. Br J Clin Pharmacol (1980) 0.77
Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods. J Antimicrob Chemother (1990) 0.77
The effects of once-daily dosing with ranitidine and cimetidine on theophylline pharmacokinetics. Eur J Drug Metab Pharmacokinet (1989) 0.76
No effect of food intake on clobazam absorption. Br J Clin Pharmacol (1983) 0.76
Rapid anticonvulsant monitoring in an epilepsy clinic. Arch Dis Child (1990) 0.75
Carbamazepine 10,11-epoxide in children. Br J Clin Pharmacol (1984) 0.75
Chloramphenicol and phenobarbitone--a drug interaction. Arch Dis Child (1979) 0.75
An NADPH dependent warfarin reductase in human and rat liver and kidney soluble fraction. Br J Pharmacol (1975) 0.75
The influence of dose-delivery time interval on neonatal plasma pethidine levels. Acta Obstet Gynecol Scand (1983) 0.75
Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens. Diabet Med (1988) 0.75
The metabolic fate of stiripentol in man. Drug Metab Dispos (1987) 0.75
Test-retest reliability of the ulnar F-wave minimum latency versus ulnar distal motor latency in healthy adults. Electromyogr Clin Neurophysiol (2001) 0.75
Pharmacokinetic consequences of product stereoselectivity in the metabolism of nafimidone: estimation of fraction metabolized. J Pharm Sci (1991) 0.75
Carbamazepine for childhood seizures. Dev Med Child Neurol (1978) 0.75
Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions. Schweiz Rundsch Med Prax (1984) 0.75
Level of dietary protein and toxicity of tannic acid in young turkeys. Proc Nutr Soc (1975) 0.75
Carbimazole and breastfeeding. Lancet (1987) 0.75
Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection. J Antimicrob Chemother (1991) 0.75
[A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers]. Gastroenterol Hepatol (1999) 0.75
Plasma naloxone levels in the newborn after intravenous and intramuscular administration [proceedings]. Br J Clin Pharmacol (1979) 0.75